Routine Clinical Practice for Use of Intravitreal Aflibercept Treatment in Patients With Diabetic Macular Edema

Inclusion Criteria

• •Man or woman aged 18 years or older
• •Patient diagnosed with a visual impairment due to diabetic macular disease (as defined by HAS (Haute Autorité de Santé) recommendation).
• •Patients in whom a decision to treat with intravitreal aflibercept has been made independently of the patient enrollment in the study
• •Patient diagnosed with type 1 or 2 diabetes mellitus
• •Patient who has been given appropriate information about the study and who has given his/her written, informed consent